Clinical Study of IBI362 in Healthy Chinese Male Subjects
Status:
Completed
Trial end date:
2021-06-17
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the pharmacokinetic characteristics and safety of IBI362
lyophilized powder and IBI362 liquid formulation in healthy Chinese male subjects.